Hangzhou Biotest Biotech Co., Ltd.SSE: 688767

"HANGZHOU BIOTEST BIOTECH CO., LTD."Review Opinion and Statement on the Public Disclosure of the List of Participants under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors

· Issued by Hangzhou Biotest Biotech Co., Ltd. via Shanghai Stock Exchange

On 6ix: 6ix.com/news/hangzhou-biotest-biotech-co-ltdreview-opinion-and-statement-on-the-public-disclosure-of-the-list-of-participants-under-the-companys-2026-restricted-share-incentive-plan-issued-by-the-remuneration-and-appraisal-committee-of-the-board-of-directors

Review Opinion and Statement on the Public Disclosure of the List of Participants under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Hangzhou Biotest Biotech Co., Ltd. on 6ix

Story so far

Earlier from Hangzhou Biotest Biotech

Later from Hangzhou Biotest Biotech

All Hangzhou Biotest Biotech news releases